A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

As 2025 ends, delve into some biotech feel-good stories where the right treatment meets the right patient, almost feeling ...

Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens.

BIO-Europe Startup Spotlight returns to Lisbon in March 2026, showcasing Europe’s top early-stage biotech pitches to industry leaders.

Home to excellent research institutions, a thriving life sciences community, a strong collaborative culture, and a strategic location at the heart of Europe, Ghent is now investing in cutting-edge ...

While non-exhaustive, this list offers an overview of the year’s biotech events taking place around the world, aimed at partnering and connecting with decision makers in biopharma. If there is a ...

Over the past few years, using artificial intelligence (AI) in drug discovery has stopped being a novelty; instead, it has become part of the standard toolkit across many early-stage programs.

Vandria has taken a step forward in its bid to bring a new kind of Alzheimer’s treatment into the clinic. The Lausanne-based company shared first-in-human data for its lead candidate VNA-318 ahead of ...